### **Overview** Dharmaj Crop Guard Limited (DCGL) is a fast-growing, fully integrated agrochemical company headquartered in Ahmedabad, Gujarat. Founded in 2015 by first-generation entrepreneurs with deep experience in agrochemicals and farming, the company has evolved from a formulator into a pan-India and globally diversified player across the entire agrochemical value chain. DCGL operates through **three core business verticals**: 1. **Branded Formulations (B2C)** – Proprietary brands for farmers 2. **Institutional Formulations (B2B)** – Bulk supply to domestic and international agrochemical companies 3. **Active Ingredients (B2B)** – Manufacturing of technical-grade active ingredients and intermediates The company is public-listed (NSE/BSE), having raised ₹2,014 million through its IPO in December 2022, largely to fund its backward integration strategy. --- ### **Vertically Integrated Value Chain** A key transformation for DCGL was the **commissioning of an 8,000 TPA multi-purpose Active Ingredients (AI) and intermediates manufacturing facility at Sayakha, Bharuch, Gujarat, on January 22, 2024**. - This greenfield facility marks the company’s entry into **full value chain integration**, making DCGL a rare Indian agrochemical player with in-house capabilities in **active ingredients, intermediates, and formulations**. - The facility spans **37,000 sq. mts**, equipped with three production blocks: - Multi-purpose technicals block (capable of producing multiple molecules simultaneously) - Dedicated intermediates line - Recovery block - It includes **a DSIR-approved R&D center, NABL-accredited QC lab**, and advanced technologies for solvent recovery and distillation, ensuring high purity and sustainability. - The plant produces key molecules including: - **Pyrethroids**: Alpha Cypermethrin, Bifenthrin, Cypermethrin, Lambda Cyhalothrin, Permethrin - **Other technicals**: Chlorantraniliprole (CTPR), Thiamethoxam, Pymetrozine, Metalaxyl, Tebuconazole, Dimethomorph This backward integration strengthens **cost competitiveness, supply chain security, quality control**, and enables new revenue streams. --- ### **Manufacturing & Capacity** DCGL operates two key manufacturing assets: | Facility | Location | Capacity (TPA) | Focus | |--------|--------|--------------|-------| | Formulations Plant | Kerala GIDC, Ahmedabad | 25,500 | Full range: EC, SC, SL, WDG, WP, GR, CS, ZC, etc. | | Active Ingredients Plant | Sayakha GIDC, Bharuch | 8,000 | Technicals & Intermediates (insecticides, fungicides) | The formulations plant is **automated, scalable, and integrated**, supporting rapid response to seasonal demand. It includes a **bioreactor-based STP**, solar power, and complies with ISO and NABL standards. --- ### **Market Presence & Revenue Streams** #### **Domestic Market (India)** - **Pan-India presence**: Operations in **24 states**, up from 20 in FY23, with cluster-based geographic expansion (average of 2 states per year). - **Branded Formulations (B2C)**: - Revenue (FY25): ₹1,928 million (~20% of total revenue) - Portfolio: **134+ brands, 418 SKUs** - Distribution: **5,250+ dealers**, **18,000+ retail touchpoints**, 20 stock depots - Farmer engagement: Direct connection with **1.15 million farmers**, supported by **QR-based loyalty program (Bharat Circle)** - **Institutional Formulations (B2B)**: - Largest revenue contributor (~53–74% historically) - Serves **700+ domestic institutional clients**, including MNCs (e.g., Rallis, Coromandel), Indian majors, and underserved small formulators (<₹10 crore sales) - Offers **270+ B2B SKUs** #### **Exports** - Present in **38 countries** across **Latin America, East Africa, Middle East, Southeast Asia, and select developed markets** - Exports span **formulations and active ingredients**, customized by region: - **Bangladesh**: Exports only **formulations** (lack of local manufacturing) - **Vietnam & Indonesia**: Exports **technicals** (local formulation capabilities) - **East Africa**: Exports **finished products** for local packaging and trading - **Product Registrations**: - 590 total agrochemical product registrations - 103 **export product registrations approved**, with **168 in pipeline** - 24 technical AI registrations approved, 32 pending - Exports formulations to **115+ institutional clients**, AI to **over 3–4 countries initially**, with plans for **Brazil, USA, and EU** --- ### **Recent Financial Performance & Growth Trajectory** - **Record Revenue (FY25)**: ₹9,510 million - **Growth Trends**: - Domestic Institutional: **37% 5-year CAGR** - Branded Formulations: **25% 5-year CAGR** - Export Institutional: **12% 5-year CAGR** - **Market Share**: Still **negligible** in the ₹50,000 crore Indian agrochemical market (~1%) - **Growth Target**: **₹2,000 crore revenue by 2030**, implying **20–25% sustained annual growth** across all segments --- ### **Strategic Initiatives & Competitive Advantage** #### **1. Business Model Differentiation** Management asserts a **unique and hard-to-replicate model**, combining: - **Broad product portfolio (200+ B2B SKUs, 418 B2C SKUs)** - **Aggressive field-level demand generation** – farmer meetings, field days, demonstrations, jeep campaigns - **Digital-first engagement**: Proprietary **DMS Mobile App** for dealers (real-time billing, payments, credit tracking) - **Advanced ERP system** for seamless automation across finance, sales, supply chain, and manufacturing #### **2. Product Innovation & Portfolio Management** - **Launched 92 new products over 6 years**, including **13 in FY25** - Introduced **nutritional products**: Bioorganic potash, micronutrient (Zn, B, S), and liquid fertilizers for drip/pest control spray - Discontinued low-margin SKUs to **optimize profitability** - Expansion into **high-margin, high-potential molecules** (e.g., CTPR, Dimethomorph) with minimal competition #### **3. Public & Animal Health Expansion** - Leverages pyrethroid manufacturing for **vector control and public health** (malaria, dengue, chikungunya) - Key brands: **Dhoofon**, **Dharmexo Gel**, **Podcast 25WP** (for termiticides, larvicides, rodenticides) - Plans to establish **dedicated sales channels** for focused market penetration #### **4. Strategic Sales Focus** - **B2B**: Dedicated **7-member national sales team** for pan-India institutional coverage – rare in domestic market - **B2C**: 230+ field sales & marketing personnel conducting **on-ground demos, farmer training, loyalty programs** - Engages **over 80 lakh farmers digitally** via social media (Facebook, YouTube) --- ### **Challenges & Mitigation** - **Margin pressure** in AI segment due to start-up costs and pricing competition – addressed via **cost optimization and higher-value molecule focus** - **Regional underperformance** in Rajasthan & UP – undergoing structural overhaul, recovery targeted by FY26 - **No direct threat from Chinese imports** – company imports only **25% raw materials (not finished goods)**, with **differentiated molecules and lower exposure** - Competitive landscape: Mitigated by **broad portfolio, continuous innovation, and strong field engagement** --- ### **Future Growth Strategy** 1. **Scale Formulations Business**: Deepen presence in 10 recently entered states, replicate Gujarat’s top-5 success nationally 2. **Ramp Up Active Ingredients**: Achieve full capacity, expand global registrations, target **higher-margin technicals** 3. **Export Expansion**: Accelerate **product registrations in North/South America, EU, Australia**, build presence in untapped markets 4. **Partnerships**: Pursue **licensed formulation marketing** with global innovators (e.g., Pendiza commercialization), in-licensed partnerships 5. **Sustainability & Efficiency**: Ongoing solvent recovery enhancements, solar energy use, effluent treatment --- ### **Key Financial & Operational Metrics (as of Sep/Oct 2025)** | Metric | Value | |-------|-------| | **Revenue (FY25)** | ₹9,510 million | | **Manufacturing Capacity** | 25,500 TPA (formulations), 8,000 TPA (AIs & intermediates) | | **Product Registrations** | 590 (total), 103 export-approved, 168 in pipeline | | **B2C Distribution** | 24 states, 18,000+ touchpoints, 5,250+ dealers | | **B2B Customers** | 700+ domestic, 115+ export clients | | **Field Team** | 230+ sales & marketing personnel | | **Workforce** | ~600 employees | | **Credit Rating** | CRISIL BBB+ (Long-term), CRISIL A2 (Short-term) | ---